Details for 2019158446
Up to date per 10.04.2026
Actions
Details for 2019158446
Granted/Registered
European Patent
07.08.2019 A
30.12.2020 B1
12.08.2013
US
201361864948 P
A61K 39/00 20060101AFI20190507BHEP
Owner
Astrazeneca AB 151 85 SödertäljeSE
Representative
Representative
Häupl & Ellmeyer KG, PatentanwaltskanzleiMariahilfer Straße 50 (Eingang Kirchengasse 1)1070 WienAT
Inventor
WARD, Christinec/o MedImmune LLC One Medimmune Way Gaithersburg, Maryland 20878US
ROSKOS, Lorinc/o MedImmune LLC One Medimmune Way Gaithersburg, Maryland 20878US
WANG, Bingc/o Medimmune LLC One Medimmune Way Gaithersburg, Maryland 20878US
RAIBLE, Donald317 Lenape Drive Berwyn, Pennsylvania 19312US
Information about Fees